Oga A, Kong G, Ishii Y, Izumi H, Park C Y, Sasaki K
Department of Pathology, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan.
Cytometry. 2001 Feb 15;46(1):57-62.
Little is known about the genetic changes associated with DNA ploidy in gastric cancer (GC). The aim of this study was to identify recurrent or specific chromosomal regions of DNA sequence copy number aberrations (DSCNAs) that might harbor genes associated with DNA aneuploidy in GC.
We analyzed DSCNAs with comparative genomic hybridization and DNA ploidy by laser scanning cytometry in 16 primary intestinal-type GCs.
All GCs examined showed at least one DSCNA (loss or gain); eight were DNA diploid (DD) tumors and eight were DNA aneuploid (DA) tumors. The frequent (>30%) DSCNAs were loss of 5q14-21 and gains of 7p11-14, 8q, 20q, and Xq25-26. Recurrent amplifications (>10%) were detected at chromosomal regions 6p, 7p, and 13q. The overall number of DSCNAs was significantly greater in DA than in DD tumors (P = 0.006). Furthermore, the number of aberrations was clearly greater with 5q loss than without 5q loss (P = 0.002). Losses of 5q14-21, 9p21-pter, 16q, and 18q21-qter were preferentially detected in DA tumors.
The present observations indicate that there is a close relationship between DSCNA and DNA ploidy in intestinal-type GC and that gene(s) at 5q14-21, 9p21-pter, 16q, and/or 18q21-qter may play important roles in acquisition of DNA aneuploidy.
关于胃癌(GC)中与DNA倍性相关的基因变化,我们了解甚少。本研究的目的是确定DNA序列拷贝数畸变(DSCNA)的复发性或特定染色体区域,这些区域可能含有与GC中DNA非整倍性相关的基因。
我们通过比较基因组杂交分析DSCNA,并利用激光扫描细胞术分析16例原发性肠型GC的DNA倍性。
所有检测的GC均显示至少一种DSCNA(缺失或增益);8例为DNA二倍体(DD)肿瘤,8例为DNA非整倍体(DA)肿瘤。常见(>30%)的DSCNA为5q14 - 21缺失以及7p11 - 14、8q、20q和Xq25 - 26增益。在染色体区域6p、7p和13q检测到复发性扩增(>10%)。DA肿瘤中DSCNA的总数显著多于DD肿瘤(P = 0.006)。此外,有5q缺失时畸变数量明显多于无5q缺失时(P = 0.002)。5q14 - 21、9p21 - pter、16q和18q21 - qter缺失在DA肿瘤中更易检测到。
目前的观察结果表明,肠型GC中DSCNA与DNA倍性之间存在密切关系,并且5q14 - 21、9p21 - pter、16q和/或18q21 - qter处的基因可能在DNA非整倍性的获得中起重要作用。